| Product Code: ETC9939651 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Breast Cancer Liquid Biopsy Market - Industry Life Cycle |
3.4 United Kingdom (UK) Breast Cancer Liquid Biopsy Market - Porter's Five Forces |
3.5 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Circulating Biomarkers, 2021 & 2031F |
3.7 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of breast cancer in the UK |
4.2.2 Growing awareness about the benefits of liquid biopsy over traditional methods |
4.2.3 Technological advancements in liquid biopsy techniques |
4.3 Market Restraints |
4.3.1 High costs associated with liquid biopsy tests |
4.3.2 Regulatory challenges and approval processes |
4.3.3 Limited reimbursement policies for liquid biopsy tests |
5 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Trends |
6 United Kingdom (UK) Breast Cancer Liquid Biopsy Market, By Types |
6.1 United Kingdom (UK) Breast Cancer Liquid Biopsy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Kits, 2021- 2031F |
6.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market, By Circulating Biomarkers |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Extracellular Vesicles (EVs), 2021- 2031F |
6.2.3 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Cell-free DNA (cfDNA), 2021- 2031F |
6.2.4 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By ctRNA, 2021- 2031F |
6.2.5 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.2.6 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By cfRNA, 2021- 2031F |
6.2.7 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Breast Cancer Liquid Biopsy Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Physician Laboratories, 2021- 2031F |
6.3.5 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.3.6 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Public Health Laboratories, 2021- 2031F |
6.3.7 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.8 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
6.3.9 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
7 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Export to Major Countries |
7.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Imports from Major Countries |
8 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Key Performance Indicators |
8.1 Adoption rate of liquid biopsy tests among healthcare providers in the UK |
8.2 Number of research studies and publications on breast cancer liquid biopsy in the UK |
8.3 Investment in RD for improving liquid biopsy technologies in the UK |
9 United Kingdom (UK) Breast Cancer Liquid Biopsy Market - Opportunity Assessment |
9.1 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Circulating Biomarkers, 2021 & 2031F |
9.3 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United Kingdom (UK) Breast Cancer Liquid Biopsy Market - Competitive Landscape |
10.1 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Breast Cancer Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here